FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026
What changed: The Drug Supply Chain Security Act (DSCSA) is now being enforced at the medical practice level. Any practice that purchases, stores, or administers drug products in-office is subject to FDA supply chain compliance inspections not just manufacturers, wholesale distributors, and retail pharmacies. Primary care practices may not administer the highest-cost drugs in medicine, but they administer a wide variety of Rx drug products daily and the FDA’s inspection methodology applies equally regardless of practice size, specialty, or drug cost.
The Drug Products at Issue in Primary Care Practices
If your practice purchases and administers any of the following, federal drug supply chain requirements apply regardless of practice size or patient volume:
INJECTABLE MEDICATIONS & IN-OFFICE TREATMENTS
• Corticosteroids (triamcinolone, methylprednisolone, dexamethasone)
• Vitamin B12 (cyanocobalamin) injectable
• Testosterone (cypionate, enanthate) injectable
• Toradol (ketorolac) injectable NSAID
• Phenergan / Zofran injectable antiemetics
• Lidocaine / Bupivacaine local anesthetics for in-office procedures
WEIGHT MANAGEMENT & METABOLIC THERAPIES
• GLP-1 agonists (semaglutide, tirzepatide) branded and compounded
• Saxenda (liraglutide) weight management injectable
• Peptide therapies (BPC-157, Ipamorelin, Sermorelin) if dispensed
• Compounded weight loss formulations from 503A/503B facilities
• Ozempic / Wegovy / Mounjaro / Zepbound if stocked in-office
• NAD+ and vitamin IV infusions with Rx components if offered
VACCINES & PREVENTIVE BIOLOGICS
• Influenza vaccines all in-office stocked formulations
• Pneumococcal vaccines (Prevnar 20, Pneumovax 23)
• Shingrix (zoster vaccine recombinant) two-dose series
• Tdap / Td boosters Adacel, Boostrix, Tenivac
• HPV vaccine (Gardasil 9) multi-dose series
• COVID-19 vaccines any stocked for in-office administration
CHRONIC DISEASE & SPECIALTY INJECTABLES
• Depo-Provera (medroxyprogesterone) contraceptive injectable
• Prolia (denosumab) osteoporosis biologic
• Forteo / Tymlos (teriparatide / abaloparatide) bone anabolic agents
• Dupixent (dupilumab) if administered in-office
• Allergy immunotherapy serums custom-prepared Rx products
• Iron infusion products (Injectafer, Venofer) if infusion services offered
Copyright © 2026 claritasaxis.com - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.